Annual EBITDA
-$111.56M$43.73M-64.46%
Summary
- Current Value
- As of today, ATXS annual EBITDA is -$111.56M, down -64.46% on
- Historical Performance
- ATXS annual EBITDA is down -267.46% over the past 3 years, and down -312.23% over the past 5 years
- All-Time High Comparison
- ATXS annual EBITDA is currently -626.95% below its historical high of -$15.35M set on
- 3-Year Low Comparison
- ATXS annual EBITDA is at its 3-year low
- Sector Comparison
- ATXS annual EBITDA is higher than 14.84% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$111.56M | -64.5% | -267.5% | -312.2% | -627.0% | |
| Quarterly EBITDA | -$34.10M | -17.5% | -175.3% | -213.9% | -674.0% | |
| TTM EBITDA | -$136.51M | -35.2% | -180.2% | -675.3% | -2998.3% | |
| Price | $13.17 | +57.7% | -12.8% | -7.0% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual EPS | -$1.68 | +30.6% | +93.2% | +88.1% | +97.3% | |
| -$111.56M | -64.5% | -267.5% | -311.8% | -611.8% | ||
| Annual Net Income | -$94.26M | -29.3% | +51.6% | -258.5% | -501.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$53.50M | N/A | -108.5% |
| 5Y | -$30.36M | -267.5% | |
| All | -$15.35M | -627.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$111.56M | at low | |
| 5Y | -$111.56M | at low | |
| All | -$111.56M | at low |
EBITDA History
FAQ
What is the current annual EBITDA of ATXS?
As of today, ATXS annual EBITDA is -$111.56M
What is 1-year change in ATXS annual EBITDA?
ATXS annual EBITDA is down -64.46% year-over-year
What is 3-year change in ATXS annual EBITDA?
ATXS annual EBITDA is down -267.46% over the past 3 years
How far is ATXS annual EBITDA from its all-time high?
ATXS annual EBITDA is currently -626.95% below its historical high of -$15.35M set on December 1, 2012
How does ATXS annual EBITDA rank versus sector peers?
ATXS annual EBITDA is higher than 14.84% of companies in Healthcare sector
When is ATXS next annual earnings release?
The next annual earnings release for ATXS is on
Quarterly EBITDA
-$34.10M$1.72M+4.79%
Summary
- Current Value
- As of today, ATXS quarterly EBITDA is -$34.10M, up +4.79% on
- Historical Performance
- ATXS quarterly EBITDA is down -17.54% year-over-year, and down -175.34% over the past 3 years
- All-Time High Comparison
- ATXS quarterly EBITDA is currently -674.04% below its historical high of -$4.41M set on
- 3-Year Low Comparison
- ATXS quarterly EBITDA is +7.81% above its 3-year low of -$37.00M reached on
- Sector Comparison
- ATXS quarterly EBITDA is higher than 12.29% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$34.10M | +4.8% | -17.5% | -175.3% | -213.9% | |
| Annual EBITDA | -$111.56M | – | -64.5% | -267.5% | -312.2% | |
| TTM EBITDA | -$136.51M | -3.9% | -35.2% | -180.2% | -675.3% | |
| Price | $13.17 | +55.9% | +57.7% | -12.8% | -7.0% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $706.00K | +100.0% | +100.0% | +100.0% | +100.0% | |
| Quarterly EPS | -$0.55 | +4.3% | -28.6% | +37.5% | +83.7% | |
| -$34.10M | +4.8% | -17.5% | -175.3% | -213.9% | ||
| Quarterly Net Income | -$31.64M | +4.3% | -29.0% | -163.8% | -191.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$29.59M | N/A | -15.3% |
| 3Y | -$13.49M | -152.8% | |
| 5Y | -$5.47M | -523.1% | |
| All | -$4.41M | -674.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$37.00M | +7.8% | |
| 3Y | -$37.00M | +7.8% | |
| 5Y | -$37.00M | +7.8% | |
| All | -$37.00M | +7.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ATXS?
As of today, ATXS quarterly EBITDA is -$34.10M
What is ATXS quarterly EBITDA most recent change?
ATXS quarterly EBITDA was up +4.79% on September 30, 2025
What is 1-year change in ATXS quarterly EBITDA?
ATXS quarterly EBITDA is down -17.54% year-over-year
How far is ATXS quarterly EBITDA from its all-time high?
ATXS quarterly EBITDA is currently -674.04% below its historical high of -$4.41M set on March 31, 2014
How does ATXS quarterly EBITDA rank versus sector peers?
ATXS quarterly EBITDA is higher than 12.29% of companies in Healthcare sector
When is ATXS next earnings release?
The next earnings release for ATXS is on
TTM EBITDA
-$136.51M$5.09M-3.87%
Summary
- Current Value
- As of today, ATXS TTM EBITDA is -$136.51M, down -3.87% on
- Historical Performance
- ATXS TTM EBITDA is down -35.20% year-over-year, and down -180.19% over the past 3 years
- All-Time High Comparison
- ATXS TTM EBITDA is currently -2998.28% below its historical high of -$4.41M set on
- 3-Year Low Comparison
- ATXS TTM EBITDA is at its 3-year low
- Sector Comparison
- ATXS TTM EBITDA is higher than 12.29% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$136.51M | -3.9% | -35.2% | -180.2% | -675.3% | |
| Annual EBITDA | -$111.56M | – | -64.5% | -267.5% | -312.2% | |
| Quarterly EBITDA | -$34.10M | +4.8% | -17.5% | -175.3% | -213.9% | |
| Price | $13.17 | +55.9% | +57.7% | -12.8% | -7.0% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $706.00K | +100.0% | +100.0% | +100.0% | +100.0% | |
| TTM EPS | -$2.15 | -6.0% | -2.7% | +41.0% | +83.3% | |
| -$136.51M | -3.9% | -35.2% | -180.2% | -287.8% | ||
| TTM Net Income | -$124.03M | -6.1% | -24.0% | -158.1% | -255.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$111.56M | N/A | -22.4% |
| 3Y | -$51.62M | -164.5% | |
| 5Y | -$19.84M | N/A | -588.0% |
| All | -$4.41M | -2998.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$136.51M | at low | |
| 3Y | -$136.51M | at low | |
| 5Y | -$136.51M | at low | |
| All | -$136.51M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ATXS?
As of today, ATXS TTM EBITDA is -$136.51M
What is ATXS TTM EBITDA most recent change?
ATXS TTM EBITDA was down -3.87% on September 30, 2025
What is 1-year change in ATXS TTM EBITDA?
ATXS TTM EBITDA is down -35.20% year-over-year
How far is ATXS TTM EBITDA from its all-time high?
ATXS TTM EBITDA is currently -2998.28% below its historical high of -$4.41M set on March 31, 2014
How does ATXS TTM EBITDA rank versus sector peers?
ATXS TTM EBITDA is higher than 12.29% of companies in Healthcare sector
When is ATXS next earnings release?
The next earnings release for ATXS is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- ATXS Official Website www.astriatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1454789/000110465925110377/0001104659-25-110377-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1454789/000141057825000309/0001410578-25-000309-index.htm
- ATXS Profile on Yahoo Finance finance.yahoo.com/quote/ATXS
- ATXS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/atxs